Bifidobacteria and Butyrate-Producing Colon Bacteria: Importance and Strategies for Their Stimulation in the Human Gut
- PMID: 27446020
- PMCID: PMC4923077
- DOI: 10.3389/fmicb.2016.00979
Bifidobacteria and Butyrate-Producing Colon Bacteria: Importance and Strategies for Their Stimulation in the Human Gut
Abstract
With the increasing amount of evidence linking certain disorders of the human body to a disturbed gut microbiota, there is a growing interest for compounds that positively influence its composition and activity through diet. Besides the consumption of probiotics to stimulate favorable bacterial communities in the human gastrointestinal tract, prebiotics such as inulin-type fructans (ITF) and arabinoxylan-oligosaccharides (AXOS) can be consumed to increase the number of bifidobacteria in the colon. Several functions have been attributed to bifidobacteria, encompassing degradation of non-digestible carbohydrates, protection against pathogens, production of vitamin B, antioxidants, and conjugated linoleic acids, and stimulation of the immune system. During life, the numbers of bifidobacteria decrease from up to 90% of the total colon microbiota in vaginally delivered breast-fed infants to <5% in the colon of adults and they decrease even more in that of elderly as well as in patients with certain disorders such as antibiotic-associated diarrhea, inflammatory bowel disease, irritable bowel syndrome, obesity, allergies, and regressive autism. It has been suggested that the bifidogenic effects of ITF and AXOS are the result of strain-specific yet complementary carbohydrate degradation mechanisms within cooperating bifidobacterial consortia. Except for a bifidogenic effect, ITF and AXOS also have shown to cause a butyrogenic effect in the human colon, i.e., an enhancement of colon butyrate production. Butyrate is an essential metabolite in the human colon, as it is the preferred energy source for the colon epithelial cells, contributes to the maintenance of the gut barrier functions, and has immunomodulatory and anti-inflammatory properties. It has been shown that the butyrogenic effects of ITF and AXOS are the result of cross-feeding interactions between bifidobacteria and butyrate-producing colon bacteria, such as Faecalibacterium prausnitzii (clostridial cluster IV) and Anaerostipes, Eubacterium, and Roseburia species (clostridial cluster XIVa). These kinds of interactions possibly favor the co-existence of bifidobacterial strains with other bifidobacteria and with butyrate-producing colon bacteria in the human colon.
Keywords: arabinoxylan-oligosaccharides; bifidobacteria; butyrate-producing colon bacteria; cross-feeding; inulin-type fructans; prebiotics; probiotics.
Figures




Similar articles
-
Complementary Mechanisms for Degradation of Inulin-Type Fructans and Arabinoxylan Oligosaccharides among Bifidobacterial Strains Suggest Bacterial Cooperation.Appl Environ Microbiol. 2018 Apr 16;84(9):e02893-17. doi: 10.1128/AEM.02893-17. Print 2018 May 1. Appl Environ Microbiol. 2018. PMID: 29500265 Free PMC article.
-
Mutual Cross-Feeding Interactions between Bifidobacterium longum subsp. longum NCC2705 and Eubacterium rectale ATCC 33656 Explain the Bifidogenic and Butyrogenic Effects of Arabinoxylan Oligosaccharides.Appl Environ Microbiol. 2015 Nov;81(22):7767-81. doi: 10.1128/AEM.02089-15. Epub 2015 Aug 28. Appl Environ Microbiol. 2015. PMID: 26319874 Free PMC article.
-
Bifidobacterial inulin-type fructan degradation capacity determines cross-feeding interactions between bifidobacteria and Faecalibacterium prausnitzii.Int J Food Microbiol. 2016 Aug 16;231:76-85. doi: 10.1016/j.ijfoodmicro.2016.05.015. Epub 2016 May 12. Int J Food Microbiol. 2016. PMID: 27233082
-
Summer Meeting 2013: growth and physiology of bifidobacteria.J Appl Microbiol. 2014 Mar;116(3):477-91. doi: 10.1111/jam.12415. Epub 2013 Dec 20. J Appl Microbiol. 2014. PMID: 24314205 Review.
-
Prebiotic inulin-type fructans and galacto-oligosaccharides: definition, specificity, function, and application in gastrointestinal disorders.J Gastroenterol Hepatol. 2017 Mar;32 Suppl 1:64-68. doi: 10.1111/jgh.13700. J Gastroenterol Hepatol. 2017. PMID: 28244671 Review.
Cited by
-
Dysbiosis of Gut Microbiota and Short-Chain Fatty Acids in Encephalitis: A Chinese Pilot Study.Front Immunol. 2020 Aug 20;11:1994. doi: 10.3389/fimmu.2020.01994. eCollection 2020. Front Immunol. 2020. PMID: 32973805 Free PMC article.
-
The Hygiene Hypothesis - Learning From but Not Living in the Past.Front Immunol. 2021 Mar 16;12:635935. doi: 10.3389/fimmu.2021.635935. eCollection 2021. Front Immunol. 2021. PMID: 33796103 Free PMC article. Review.
-
Integrated gut microbiome and metabolome analyses identified fecal biomarkers for bowel movement regulation by Bifidobacterium longum BB536 supplementation: A RCT.Comput Struct Biotechnol J. 2022 Oct 25;20:5847-5858. doi: 10.1016/j.csbj.2022.10.026. eCollection 2022. Comput Struct Biotechnol J. 2022. PMID: 36382178 Free PMC article.
-
Therapeutic Antiaging Strategies.Biomedicines. 2022 Oct 8;10(10):2515. doi: 10.3390/biomedicines10102515. Biomedicines. 2022. PMID: 36289777 Free PMC article. Review.
-
Parenteral Antimicrobial Treatment Diminishes Fecal Bifidobacterium Quantity but Has No Impact on Health in Neonatal Dairy Calves: Data From a Field Trial.Front Vet Sci. 2021 Mar 31;8:637271. doi: 10.3389/fvets.2021.637271. eCollection 2021. Front Vet Sci. 2021. PMID: 33869318 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical